Premium
Combined hereditary factor XI (plasma thromboplastin antecedent) deficiency, von Willebrand's disease, and xeroderma pigmentosum in a Japanese family
Author(s) -
Sano Masayuki,
Saito Hidehiko,
Shimamoto Yoshinori,
Sugiura Isamu,
Ohtsubo Haruhiko,
Kohda Hiromu,
Yamaguchi Masaya
Publication year - 1993
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.2830440211
Subject(s) - factor xi , xeroderma pigmentosum , von willebrand disease , medicine , von willebrand factor , partial thromboplastin time , endocrinology , clotting factor , platelet , immunology , chemistry , coagulation , biochemistry , gene , dna repair
We report a 28‐year‐old‐Japanese male who had a skin tumor derived from variant type xeroderma pigmentosum (XP), combined with factor XI (FXI) deficiency and type IIB von Willebrand's disease (vWd). The patient had abnormal bleeding history on tooth extraction. FXI clotting activity (FXI:C) and antigen (FXI:Ag) were remarkably decreased (<0.01 U/ml, <0.02 U/ml, respectively). Factor VIII (FVIII) clotting activity, von Wiliebrand factor antigen (vWf :Ag), and ristocetin cofactor (RCoF) were 0.43 U/ml, 45%, and 57%, respectively. Ristocetin‐induced platelet agglutination (RIPA) revealed hyper‐aggregation compared with a normal control. Multimeric composition of vWf in plasma showed a reduction in high molecular weight forms. The family study revealed two other subjects with ho‐mozygous hereditary FXI deficiency and vWd, and five subjects with heterozygous FXI deficiency. The relationship between FXI deficiency and vWd is discussed and previously reported cases are reviewed. © 1993 Wiley‐Liss, Inc.